edoc

Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration

Imfeld-Isenegger, Tamara Leila and Soares, Inês Branco and Makovec, Urska Nabergoj and Horvat, Nejc and Kos, Mitja and van Mil, Foppe and Costa, Filipa A. and Hersberger, Kurt E.. (2019) Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration. Research in Social and Administrative Pharmacy . j.apharm.2019.11.002.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/74584/

Downloads: Statistics Overview

Abstract

Pharmaceutical Care Network Europe (PCNE) proposed a definition and classification system (type 1, 2a, 2b, 3) for medication review in 2016. However, to date, a description of the implementation and remuneration of such procedures across Europe is lacking.; The aim of this study was to describe the medication review procedures and the level of implementation and remuneration in community pharmacies across Europe.; An online survey was developed to characterize medication review procedures (PCNE classification), level of implementation (considering regional or national) and remuneration by a third party. This survey was sent to a purposive sample of three individuals per country, with a working background in community pharmacy, pharmacy practice research, or health policy to ensure reliable data. Data triangulation was used and consensus sought between the responses.; Data were received from 34 out of 44 targeted European countries (November 2016-October 2017) [response rate = 77%]. Overall, 55.9% of the countries provided at least one type of medication review as an implemented service or project. Type 1 medication review (based on the medication history) was provided in 13 countries, type 2a (medication history + patient interview) in 14, type 2b (medication history + clinical data) in two, and type 3 medication review (medication history + patient interview + clinical data) in four countries. Ten of the mentioned services or projects were remunerated by a third-party.; Substantial heterogeneity was observed across Europe in various aspects, including the procedures, implementation level and remuneration obtained. Type 1 and 2a medication review services seem to be more feasible to implement in the community pharmacy than type 2b and 3. A large number of medication review projects were ongoing in community pharmacies, which suggests that new medication review services could become implemented in the coming years.
Faculties and Departments:05 Faculty of Science > Departement Pharmazeutische Wissenschaften > Pharmazie > Pharmaceutical Care (Hersberger)
UniBasel Contributors:Hersberger, Kurt E. and Imfeld-Isenegger, Tamara
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Elsevier
ISSN:1551-7411
e-ISSN:1934-8150
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:21 May 2020 10:05
Deposited On:21 May 2020 10:05

Repository Staff Only: item control page